Sandip Kapadia, Chief Financial Officer at INTERCEPT PHARMACEUTICALS INC (ICPT), sold 2,862 shares at $121.59 ($348K) on 2017-07-03, disclosed to the SEC on 2017-07-05.
Open-market sale of $348k ICPT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $121.59 | 1,431 | $174K | 50.0% |
| 2 | $121.59 | 1,431 | $174K | 50.0% |
| Total | $121.59 avg | 2,862 | $348K | 100% |
| Filing → |
| HRMY | SELL | 2025-12-09 | $791K | — | Filing → |
| HRMY | SELL | 2025-11-25 | $120K | — | Filing → |
| HRMY | SELL | 2025-08-19 | $1.6M | — | Filing → |